West Pharmaceutical Services Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
West Pharmaceutical Services Stock Forecast and Price Target
The average price target for West Pharmaceutical Services's stock set by two recognized analysts recently is $380.00, which would result in a potential downside of approximately -1.49% if it reached this mark. The estimation is based on a high estimate of $470.00 and a low estimate of $336.00. If you are not interested in WST stock, you may still be interested in its competitors and their current standings.
-1.49% Downside
West Pharmaceutical Services Fair Value Forecast for 2023 - 2025 - 2030
West Pharmaceutical Services's Price has decreased by 100.00% In the last four years, from $210.44 to $0.00. In the next year, analysts believe that Fair Value will reach $388.61 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$375.01 | Buy/Sell | $408.45 | 14.66% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$336.85 | Buy/Sell | $353.16 | 8.80% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.61 | Buy/Sell | $91.18 | 9.47% |
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$494.26 | Buy/Sell | $583.92 | 21.39% |
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$183.78 | Buy/Sell | $201.32 | 11.55% |
West Pharmaceutical Services Revenue Forecast for 2023 - 2025 - 2030
West Pharmaceutical Services's Revenue has seen impressive growth In the last three years, rising from $2.15B to $2.95B – a growth of 37.40%. In the next year, analysts believe that Revenue will reach $3.22B – an increase of 9.29%. For the next seven years, the forecast is for Revenue to grow by 24.85%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.24k | Buy/Sell | $1.12k | -0.43% |
| ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$121.17 | Buy/Sell | $132.52 | 12.24% |
| BALL Stock Forecast | Ball | Hold |
14
|
$65.19 | Buy/Sell | $58.78 | -0.29% |
.jpg)
West Pharmaceutical Services Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, West Pharmaceutical Services's Dividend per Share has grown by 18.46%, rising from $0.65 to $0.77. For the next year, analysts predict that Dividend per Share will reach $0.99 – an increase of 28.57%. Over the next seven years, experts believe that West Pharmaceutical Services's Dividend per Share will grow at a rate of 57.11%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STE Stock Forecast | STERIS | Outperform |
13
|
$202.80 | Buy/Sell | $238.33 | 18.84% |
| COO Stock Forecast | The Cooper Companies | Outperform |
13
|
$90.20 | Buy/Sell | $391.40 | 21.95% |
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$76.71 | Buy/Sell | $81.06 | 9.50% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PKG Stock Forecast | Packaging Corporation of Ameri... | Hold |
6
|
$173.92 | Buy/Sell | $165.25 | 4.07% |
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$102.68 | Buy/Sell | $121.84 | 21.62% |
| PODD Stock Forecast | Insulet | Outperform |
15
|
$167.25 | Buy/Sell | $222.05 | 41.11% |
West Pharmaceutical Services EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, West Pharmaceutical Services's EBITDA has seen an increase, rising from $529.20M to $811.20M. This represents a growth of 53.29%. Analysts predict that West Pharmaceutical Services's EBITDA will increase in the upcoming year, reaching $943.65M. This would represent an increase of 16.33%. Over the next seven years, experts predict that West Pharmaceutical Services's EBITDA will grow at a rate of 40.81%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$211.17 | Buy/Sell | $263.46 | 25.49% |
| CHE Stock Forecast | Chemed Corp | Outperform |
18
|
$617.95 | Buy/Sell | $611.33 | 12.71% |
| XRAY Stock Forecast | DENTSPLY SIRONA | Outperform |
17
|
$30.92 | Buy/Sell | $36.00 | 20.63% |
West Pharmaceutical Services EBIT Forecast for 2023 - 2025 - 2030
West Pharmaceutical Services's EBIT has seen growth In the last three years, going from $420.10M to $676.00M – a gain of 60.91% In the next year, analysts believe that EBIT will reach $790.28M – an increase of 16.91%. For the next seven years, the forecast is forEBIT to grow by 44.19%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GETI B Stock Forecast | Getinge AB | Outperform |
18
|
kr232.30 | Buy/Sell | kr226.10 | -2.93% |
| SON Stock Forecast | Sonoco Products | Outperform |
14
|
$56.61 | Buy/Sell | $58.67 | 6.69% |
| YPSN Stock Forecast | Ypsomed Holding | Buy |
18
|
CHF359.00 | Buy/Sell | CHF330.00 | -8.08% |
West Pharmaceutical Services EPS Price Prediction Forecast for 2023 - 2025 - 2030
West Pharmaceutical Services's EPS has decreased by 100.00% In the last four years, from $4.76 to $0.00. In the next year, analysts believe that EPS will reach $8.79 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SEE Stock Forecast | Sealed Air | Outperform |
16
|
$31.72 | Buy/Sell | $43.25 | 35.56% |
| SLGN Stock Forecast | Silgan Holdings | Outperform |
18
|
$47.32 | Buy/Sell | $46.73 | 13.59% |
| FUL Stock Forecast | H.B. Fuller | Outperform |
18
|
$75.06 | Buy/Sell | $84.50 | 19.90% |
Site Navigation
.jpg)